Lv41
760 积分 2022-09-21 加入
Radioactive ADME Demonstrates ARV-110’s High Druggability Despite Low Oral Bioavailability
2天前
已完结
Discovery of a Novel Macrocyclic Noncovalent CDK7 Inhibitor for Cancer Therapy
11天前
已完结
Discovery of 4-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide (FN-1501), an FLT3- and CDK-Kinase Inhibitor with Potentially High Efficiency against Acute Myelocytic Leukemia
17天前
已完结
1-Acyl-1H-[1,2,4]triazole-3,5-diamine Analogues as Novel and Potent Anticancer Cyclin-Dependent Kinase Inhibitors: Synthesis and Evaluation of Biological Activities
17天前
已完结
Abstract 5979: TY-0540, a highly potent CDK2/4/6 inhibitor, attenuates acquired resistance against CDK4/6 inhibition
18天前
已关闭
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
22天前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
24天前
已完结
CCNE1Amplification as a Therapeutic Target
24天前
已完结
Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV Infection
29天前
已完结
Management of Adverse Events Due to Cyclin-Dependent Kinase 4/6 Inhibitors
29天前
已完结
皖公网安备34019202002308
